MedCrypt widens Cybersecurity partnerships with diabetes technology companies for digital innovations

CIOTechOutlook Team | Wednesday, 15 February 2023, 03:21 IST

  •  No Image
In order to help the next generation of diabetes technology reach the market faster with security built in by design, MedCrypt, Inc., the proactive cybersecurity solution provider for medical device manufacturers, today announced its collaboration with six diabetes care technology providers, including the top producers of insulin pumps and continuous glucose monitors.
 
Approximately 350,000 Americans who use insulin pumps daily are among the 37.3 million who have diabetes, according to estimates. Insulin pumps and glucose monitors may pose cybersecurity hazards, according to the Food and Drug Administration (FDA), which has kept track of the issue. It has been noted that these devices may be vulnerable to hacking when being paired with other system elements like cellphones. 
 
These devices must be dependable and trustworthy due to the great benefits they offer. Given that so many diabetic devices are interconnected, increasingly operate together, and administer doses that can save lives, it's critical that they only use authorised and authenticated components.
 
"Diabetes is a constant disruption in the lives of millions of people, and digital tech brings peace and convenience so that people living with diabetes can control their own health," said Mike Kijewski, CEO of MedCrypt. "But digital innovation requires security innovation, too. The devices themselves need to 'trust' each other through the binding of a unique cryptographic certificate to a device. This area of digital technology couldn't be more closely in line with why MedCrypt exists. We are solving the unique security challenges in digital healthcare – at scale – so that our customers can confidently build the clinical innovations of the future."
 
"The need for proactive cybersecurity within diabetes devices is growing; with the benefits of connected devices comes the potential to expose multiple connected devices to cyber threats," said Naomi Schwartz, Senior Director of Quality and Safety at MedCrypt. Her background includes working at the FDA to evaluate software and cybersecurity for the world's first regulated Automated Insulin Delivery (AID) System and developing Class II regulatory pathways for the three major components of AID systems, a game-changer for supporting patients with insulin-dependent diabetes. "Data indicates that physicians and pharmacists in hospitals are thinking about security and that they need clearer information about privacy, security & data sharing before prescribing diabetes tech to their patients. 
 
But with this in mind, healthcare providers can't be specialists in the technology itself and the potential privacy issues. They need a specialist to provide security and privacy assurances; MedCrypt is empowering companies to move faster, designing better, more secure, connected devices, allowing practitioners to prescribe devices without concern about the security of connectivity."
 
"People living with diabetes are the best experts in their chronic condition. They live with these devices every day; we couldn't possibly know more about the impact of their devices than they do," said Shannon Lantzy, MedCrypt's vice president of consulting. "We understand how important interoperability is. MedCrypt partners with manufacturers to build technology that provides trust, transparency, interoperability, and choices."
 
Seven of the top ten medical device manufacturers, startups, and mid-sized businesses, including the top producers of surgical robotics technologies and virtual reality applications for minimally invasive surgery, rely on MedCrypt for better security products and services.
 
Early in November 2022, MedCrypt announced a $25M Series B funding round. Dexcom Ventures then contributed a further investment in January 2023. With these financing, the company plans to expand the usage of its vulnerability management, behaviour tracking, and cryptography technologies across a range of medical devices, including glucose metres and other diabetes equipment. Visit medcrypt.com for more details on MedCrypt and its selection of security solutions.